Informatie:
Fout:
ID
34161
Beschrijving
Acupuncture to Prevent Chemotherapy Dose Reduction Due to Chemotherapy-induced Peripheral Neuropathy in Breast and Colorectal Cancer Patients (GCC1232); ODM derived from: https://clinicaltrials.gov/show/NCT01881932
Link
https://clinicaltrials.gov/show/NCT01881932
Trefwoorden
Versies (1)
- 14-01-19 14-01-19 -
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
14 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Cancer NCT01881932
Eligibility Breast Cancer NCT01881932
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT01881932
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
histologically proven stage i-iii carcinoma of the breast or histologically proven stage i-iii colorectal carcinoma.
boolean
ID.2
Item
receiving adjuvant or neoadjuvant chemotherapy that includes a taxane or oxaliplatin.
boolean
ID.3
Item
while on chemotherapy, develop greater than or equal to nci-ctc grade 2 cipn.
boolean
ID.4
Item
eastern cooperative oncology group performance status 0-2.
boolean
ID.5
Item
the patient is aware of the nature of his/her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form.
boolean
ID.6
Item
prior acupuncture within one year of enrollment.
boolean
ID.7
Item
known metastatic (stage iv) breast or colorectal cancer involvement.
boolean
ID.8
Item
pre-existing peripheral neuropathy before chemotherapy is initiated
boolean
ID.9
Item
currently taking anti-neuropathy medication such as gabapentin, or pregabalin.
boolean